Business Context and Reporting Period
This Form 8-K is a current report filed by BioSig Technologies, Inc. (not Streamex Corp.) on August 5, 2020, covering events occurring between July 30, 2020 and August 4, 2020. The company is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM. The filing primarily serves as a Regulation FD disclosure regarding recent press releases and operational milestones.
Key Financial Metrics
The filing text does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity figures. This report focuses on corporate events rather than financial performance results.
Material Changes and Operational Updates
- Executive Presentation: CEO Kenneth L. Londoner is scheduled to present at the Proactive Investors One2One Virtual Event on August 4, 2020.
- Government Contracting Status: The company was awarded its Commercial and Government Entity (CAGE) code by the Systems for Award Management (SAM), a prerequisite for bidding on government contracts.
- Clinical Study Expansion: The company installed its PURE EP(tm) System at Massachusetts General Hospital (MGH) as part of an expanding clinical study.
Guidance, Outlook, and Risks
The filing contains no forward-looking financial guidance, earnings outlook, or specific risk factor updates beyond standard disclaimers. Management explicitly states it undertakes no obligation to update, supplement, or amend the attached press release materials. The information provided is not deemed "filed" for liability purposes under Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the company name is BioSig Technologies, Inc. (BSGM), as the request metadata incorrectly listed "Streamex Corp."
- Confirm the operational significance of the CAGE code award for future government revenue potential.
- Review the attached press releases (Exhibits 99.1, 99.2, 99.3) for details on the MGH clinical study scope.
- Note that no financial performance data is included in this specific filing; refer to the latest 10-Q or 10-K for financial metrics.